Park Ha Biological Technology Co Ltd risk profile
59 Elevated one input has moved against it
Measured 1 September 2026 from BYAH's filed statements. Recomputed nightly.
59 (Elevated), driven by Market expectation at 80, over 4 weighted categories on the MANUFACTURER profile.
What is measured
| Mechanism | Reading | Band | Direction | Driver |
|---|---|---|---|---|
| Market expectation | 80 | Acute | Volatile | One-year price volatility — 4,712.1% |
| Operating pressure | Reads cost_of_revenue, operating_expense, operating_income and revenue. No reading is stored for this company. | |||
| Cash conversion | 72 | Stretched | Worsening | Capital spending against operating cash — 1.03x |
| Leverage and coverage | 39 | Normal | Worsening | Interest cover — -586,330.05x |
| Competitive position | 58 | Elevated | Stable | Operating-margin gap against peers — -947.7 percentage points |
| Concentration | Reads identified supplier spend, customers above the 10% disclosure threshold and revenue by region. No reading is stored for this company. | |||
These are descriptive readings of disclosed mechanisms, not investment advice, and not a prediction. A band says where a measured input sits, never what to do about it or what happens next.
Consumer Defensive companies with a risk reading
Walmart Inc 43Costco Wholesale Corp 40Coca-Cola Company 30Procter & Gamble Company 34Philip Morris International Inc 24Nestle S.A. 45Nestlé S.A 45L'Oréal S.A. 32PepsiCo Inc 43Anheuser-Busch InBev SA/NV 35Unilever plc 42Unilever PLC 42
Financials, valuation and price history for Park Ha Biological Technology Co Ltd